XML 35 R28.htm IDEA: XBRL DOCUMENT v3.25.1
EQUITY AWARDS (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity

A summary of stock option activity in the Plan during the three months ended March 31, 2025 and 2024 follows:

Three Months Ended March 31, 2025

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life in
Years

 

 

Aggregate
Intrinsic
Value

 

Outstanding at beginning of year

 

 

393,770

 

 

$

29.24

 

 

 

5.93

 

 

$

2,739

 

Granted

 

 

5,500

 

 

 

41.11

 

 

 

 

 

 

 

Exercised

 

 

(50,890

)

 

 

25.54

 

 

 

 

 

 

 

Forfeited

 

 

(6,600

)

 

 

24.55

 

 

 

 

 

 

 

Balance, March 31, 2025

 

 

341,780

 

 

$

30.07

 

 

 

6.29

 

 

$

3,409

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at end of period

 

 

185,340

 

 

$

29.14

 

 

 

4.76

 

 

$

2,019

 

 

Three Months Ended March 31, 2024

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life in
Years

 

 

Aggregate
Intrinsic
Value

 

Outstanding at beginning of year

 

 

465,680

 

 

$

28.12

 

 

 

5.46

 

 

$

2,782

 

Granted

 

 

2,500

 

 

 

30.49

 

 

 

 

 

 

 

Exercised

 

 

(3,300

)

 

 

20.91

 

 

 

 

 

 

 

Forfeited

 

 

(10,500

)

 

 

34.84

 

 

 

 

 

 

 

Balance, March 31, 2024

 

 

454,380

 

 

$

28.03

 

 

 

5.20

 

 

$

1,632

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at end of period

 

 

294,880

 

 

$

26.28

 

 

 

3.77

 

 

$

1,378

 

Schedule of Nonvested Stock Option Activity

A summary of nonvested stock option activity in the Plan during the three months ended March 31, 2025 and 2024 follows:

Three Months Ended March 31, 2025

 

Number of
Shares

 

 

Weighted-Average
Grant
Date Fair Value

 

Nonvested at beginning of year

 

 

161,280

 

 

$

6.32

 

Granted

 

 

5,500

 

 

 

10.71

 

Vested

 

 

(10,340

)

 

 

5.88

 

Balance, March 31, 2025

 

 

156,440

 

 

$

6.51

 

 

Three Months Ended March 31, 2024

 

Number of
Shares

 

 

Weighted-Average
Grant
Date Fair Value

 

Nonvested at beginning of year

 

 

182,570

 

 

$

6.10

 

Granted

 

 

2,500

 

 

 

5.28

 

Vested

 

 

(17,170

)

 

 

5.53

 

Forfeited

 

 

(8,400

)

 

 

8.95

 

Balance, March 31, 2024

 

 

159,500

 

 

$

6.09

 

Plan Information

Information related to stock options in the Plan is as follows for the three months ended:

 

 

March 31, 2025

 

 

March 31, 2024

 

Intrinsic value of options exercised

 

$

738

 

 

$

31

 

Cash received from options exercised

 

 

1,300

 

 

 

69

 

Net exercise of options

 

 

16

 

 

 

 

Weighted average fair value of options granted

 

 

10.71

 

 

 

5.28

 

 

Summary of Restricted Stock Awards and Units Activity

A summary of restricted stock activity in the Plan during the three months ended March 31, 2025 and 2024 follows:

Three Months Ended March 31, 2025

 

Number of
Shares

 

 

Weighted-Average
 Grant
Date Fair Value

 

Nonvested at beginning of year

 

 

8,317

 

 

$

29.81

 

Granted

 

 

1,935

 

 

 

41.11

 

Vested

 

 

(1,272

)

 

 

31.97

 

Balance, March 31, 2025

 

 

8,980

 

 

$

31.93

 

Three Months Ended March 31, 2024

 

Number of
Shares

 

 

Weighted-Average
Grant
 Date Fair Value

 

Nonvested at beginning of year

 

 

15,390

 

 

$

28.87

 

Granted

 

 

2,388

 

 

 

30.49

 

Vested

 

 

(3,511

)

 

 

5.31

 

Forfeited

 

 

(221

)

 

 

34.10

 

Balance, March 31, 2024

 

 

14,046

 

 

$

29.14